XML 56 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock and Stock-Based Awards (Tables)
12 Months Ended
Dec. 31, 2023
Subsidiary, Sale of Stock [Line Items]  
Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity for the year ended December 31, 2023:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Outstanding as of December 31, 2022

 

 

14,940,034

 

 

$

10.03

 

 

 

7.25

 

 

$

11,608

 

Granted

 

 

2,508,553

 

 

 

5.44

 

 

 

 

 

 

 

Exercised

 

 

(260,640

)

 

 

3.36

 

 

 

 

 

 

 

Forfeited

 

 

(2,343,835

)

 

 

8.30

 

 

 

 

 

 

 

Outstanding as of December 31, 2023

 

 

14,844,112

 

 

$

9.64

 

 

 

5.71

 

 

$

 

Vested or expected to vest as of December 31, 2023

 

 

14,844,112

 

 

$

9.64

 

 

 

5.66

 

 

$

 

Options exercisable as of December 31, 2023

 

 

10,488,694

 

 

$

10.09

 

 

 

4.61

 

 

$

 

Summary of Restricted and Performance Stock Unit Activity The table below summarizes the Company’s RSU and PSU activity for the year ended December 31, 2023:

 

 

 

Number
of Shares

 

 

Weighted
Average Grant
Date Fair Value

 

Unvested restricted stock units as of December 31, 2022

 

 

1,549,540

 

 

$

9.37

 

Granted

 

 

4,424,479

 

 

$

4.14

 

Forfeited

 

 

(1,071,571

)

 

$

6.94

 

Vested

 

 

(1,524,644

)

 

$

7.22

 

Unvested restricted stock units as of December 31, 2023

 

 

3,377,804

 

 

$

4.26

 

Summary of Stock Based Compensation Expense

The Company recorded stock-based compensation expense related to stock options and restricted stock units in the following expense categories of its consolidated statements of operations and comprehensive loss:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Research and development expenses

 

$

19,341

 

 

$

13,429

 

 

$

10,146

 

General and administrative expenses

 

 

14,760

 

 

 

12,053

 

 

 

10,076

 

 

 

$

34,101

 

 

$

25,482

 

 

$

20,222

 

Employees Stock Option [Member]  
Subsidiary, Sale of Stock [Line Items]  
Summary of Estimated Fair Value of Employee Stock Options

The assumptions that the Company used to determine the fair value of the stock options granted to employees and directors were as follows, presented on a weighted average basis:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Risk-free interest rate

 

 

3.64

%

 

 

1.67

%

 

 

0.73

%

Expected term (in years)

 

 

6.0

 

 

 

6.0

 

 

 

5.4

 

Expected volatility

 

 

107.2

%

 

 

104.0

%

 

 

106.5

%

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

Employee Stock [Member]  
Subsidiary, Sale of Stock [Line Items]  
Summary of Estimated Fair Value of Employee Stock Options The assumptions that the Company used to determine the fair value of rights to acquire common stock under the ESPP were as follows, presented on a weighted average basis:

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Risk-free interest rate

 

 

5.01

%

 

 

2.11

%

 

 

0.97

%

Expected term (in years)

 

 

0.5

 

 

 

0.5

 

 

 

0.5

 

Expected volatility

 

 

79.1

%

 

 

99.0

%

 

 

123.8

%

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%